pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, heart failure, Read More

Classification Information

Class [005]
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for human use relating to metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents.

Classification kind code

Mark Details

Serial Number

1797932

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 42 on 11^th Jul 2018	Advertised
Submitted for opposition 26 on 21^st Jun 2018	Approved
Submitted for opposition 23 on 02^th May 2018	Default Removed
Submitted for opposition 27 on 02^th May 2018	Approval Notice Sent
Submitted for opposition 14 on 31^st Oct 2017	Default Notice Sent
Submitted for opposition 22 on 13^th Apr 2017	Search Recorded
Submitted for opposition 20 on 13^th Apr 2017	Examiner's First Report
Submitted for opposition 30 on 29^th Aug 2016	Filed
Submitted for opposition 1 on 29^th Aug 2016	Created
Submitted for opposition 31 on 29^th Aug 2016	Formalized